ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
235 hedge funds and large institutions have $3.22B invested in Array Biopharma Inc in 2018 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 83 increasing their positions, 62 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 191 → 235 (+44)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Holders
235
Holding in Top 10
7
Calls
$27.3M
Puts
$18.7M
Top Buyers
| 1 | +$50.5M | |
| 2 | +$40.2M | |
| 3 | +$25.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.2M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$20M |
Top Sellers
| 1 | -$85.9M | |
| 2 | -$59.1M | |
| 3 | -$57.9M | |
| 4 |
O
OrbiMed
New York
|
-$44.4M |
| 5 |
Morgan Stanley
New York
|
-$34.4M |